Transient arterial phase respiratory motion-related artifact

Last revised by Henry Knipe on 29 Feb 2024

Transient arterial phase respiratory motion-related artifact refers to common self-limited dyspnea observed immediately after administering gadoxetate disodium during liver MRI studies. Awareness about this potential artefact when choosing this hepatospecific contrast agent (Primovist/Eovist) is vital, as the motion degradation of the images can result in a non-diagnostic MRI.

The pathophysiology behind this phenomenon is poorly understood and its incidence is reported at ~10% (range 2.4-18%) 1-4

Although described with other gadolinium agents 5, this self-limited dyspnea is much more prevalent with gadoxetate disodium. Risk factors include prior episodes, high-volume gadoxetate, low body weight, history of iodinated contrast media allergy, chronic obstructive pulmonary disease (COPD), supplemental oxygen, and modified breath-holding 5.

A few techniques have been proposed to overcome this artifact 5:

  • slower injection rate at 1 mL/sec

  • increased gadoxetate dose

  • subtraction imaging may increase the sensitivity of arterial phase enhancement

  • multiple arterial phase acquisitions

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.